In Q4 2025, the Class Z returned 2.39% net of fees and outperformed its benchmark, the S&P UBS Leveraged Loan Index, gross of fees.
HealthWarehouse.com reported 2025 net sales of $49.0 million, a 46% increase over 2024, as partner services prescription revenues increased 87%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results